![gastroparesis glp 1 agonist Diabetic glp-1_analogs [TUSOM | Pharmwiki]](https://gertitashkomd.com/wp-content/uploads/2022/06/img_629780263314e.png)
gastroparesis glp 1 agonist Diabetic glp-1_analogs [TUSOM | Pharmwiki]
Description
hazard ratio 1.60, 95% CI 1.37 to 1.87) but not after confounding factors were accounted for (0.91, 0.73 to 1.12)
![gastroparesis glp 1 agonist Diabetic glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
Whats Next for Compounded GLP-1 Drugs
![gastroparesis glp 1 agonist Diabetic glp-1_analogs [TUSOM | Pharmwiki]](https://www.researchgate.net/publication/381959734/figure/fig1/AS:11431281271828506@1723773994524/Gastrointestinal-effect-and-adverse-effects-of-GLP-1-receptor-agonist-therapy-Created.png)
For best results, we recommend 3-6 months of consistent daily use
![gastroparesis glp 1 agonist Diabetic glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs11894-025-00995-3/MediaObjects/11894_2025_995_Fig1_HTML.png)
Upper respiratory tract infections (URTIs) were the most frequently reported adverse event (8 of 12 reporting studies, 66.7%), occurring at rates comparable to controls across RCTs (GRADE: MODERATE certainty)
![gastroparesis glp 1 agonist Diabetic glp-1_analogs [TUSOM | Pharmwiki]](https://www.aboutlawsuits.com/wp-content/uploads/GLP-1-Manufacturers-Gastroparesis-Diagnostic-Testing-SS2527996213.jpg.webp)
